Skip to content
Global markets · Independent coverage Follow a hub and receive new coverage by email.
TechStock2Market intelligence
Signalbook

NASDAQ:ARVN

Pfizer trades up with Rigel’s Veppanu deal done

Pfizer Inc. shares ticked up Tuesday after Rigel Pharmaceuticals announced it has finalized a licensing deal for Veppanu, the breast-cancer treatment Arvinas and Pfizer developed together. The move offered a small bit of news…

4 min read
NASDAQ:ARVNNASDAQ:RIGLNYSE:PFE

Company hubNASDAQ:ARVN

Pfizer’s (ARVN) Stock News & Analysis

Follow the latest Pfizer’s (ARVN) company news, earnings coverage and investor analysis from TechStock².

Save this hub to your TS2 Signalbook account.
Latest update
Articles in this hub
3
Last 30 days
0

What investors are watching

  • Earnings, guidance and financial performance
  • Valuation, trading activity and market sentiment
  • Strategy, catalysts and company-specific risks
Read latest coveragePrefer TechStock² in Google

All coverage

NASDAQ:ARVN

3 articles